Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (2013)
NICE advice (319)
Quality standard (197)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (765)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (335)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (881)
Apply filters
Showing 21 to 30 of 2013
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Acute heart failure: diagnosis and management
CG187
8 October 2014
17 November 2021
Acute kidney injury: prevention, detection and management
NG148
18 December 2019
16 October 2024
Acute upper gastrointestinal bleeding in over 16s: management
CG141
13 June 2012
25 August 2016
Acutely ill adults in hospital: recognising and responding to deterioration
CG50
25 July 2007
25 July 2007
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)
TA1076
2 July 2025
2 July 2025
Adalimumab and dexamethasone for treating non-infectious uveitis
TA460
26 July 2017
26 July 2017
Adalimumab for treating moderate to severe hidradenitis suppurativa
TA392
22 June 2016
22 June 2016
Adalimumab for treating moderate to severe plaque psoriasis
TA146
25 June 2008
25 June 2008
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
TA455
12 July 2017
12 July 2017
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
TA715
14 July 2021
14 July 2021
Previous page
1
2
Current page
3
4
5
…
202
Page
3
of
202
Next page
Results per page
10
25
50
All
Back to top